Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chr. Hansen Holding AS (CHR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12368
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It caters to the needs of agriculture, beverage, ice and desserts, meat, pharmaceuticals, dietary supplements, fermented milks, confectionery, fruit preparations, snacks, spreads and wine industries. Chr. Hansen conducts research and development in the fields of fermentation, microbial physiology, customization, screening and documentation. The company operates in Europe, Middle East and Africa (EMEA), Americas and Asia-Pacific (APAC). Chr. Hansen is headquartered in Horsholm, Denmark.

Chr. Hansen Holding AS (CHR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Prota Therapeutics Enters into Partnership with Chr. Hansen 10
Chr. Hansen Holding Enters into Partnership with Caelus Health 11
Chr. Hansen Enters into Distribution Agreement with Laboratorios Synthesis 12
Acquisition 13
Novo Acquires 25.66% Stake In Chr. Hansen Holding For US$712 Million 13
Chr. Hansen Holding A/S – Key Competitors 15
Chr. Hansen Holding A/S – Key Employees 16
Chr. Hansen Holding A/S – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Corporate Communications 19
Jun 01, 2018: Mauricio Graber commences as new CEO of Chr. Hansen Holding 19
Feb 02, 2018: Jorgen Erichsen, Executive Vice President, Natural Colors Division, forlader Chr. Hansen Holding 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chr. Hansen Holding A/S, Deals By Therapy Area, 2012 to YTD 2018 8
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prota Therapeutics Enters into Partnership with Chr. Hansen 10
Chr. Hansen Holding Enters into Partnership with Caelus Health 11
Chr. Hansen Enters into Distribution Agreement with Laboratorios Synthesis 12
Novo Acquires 25.66% Stake In Chr. Hansen Holding For US$712 Million 13
Chr. Hansen Holding A/S, Key Competitors 15
Chr. Hansen Holding A/S, Key Employees 16
Chr. Hansen Holding A/S, Subsidiaries 17

List of Figures
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chr. Hansen Holding A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Hidd Power Company:企業の戦略的SWOT分析
    Hidd Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • MVV Energie AG (MVV1):企業の財務・戦略的SWOT分析
    MVV Energie AG (MVV1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsui Fudosan Co., Ltd.:戦略・SWOT・企業財務分析
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Inventiva (IVA)-製薬・医療分野:企業M&A・提携分析
    Summary Inventiva is a drug discovery company that endeavors to develop breakthrough therapies for cancer, fibrosis and rare diseases. The company’s product pipeline includes IVA336 for mucopolysaccharidosis type VI (MPS VI) and IVA337 for systemic sclerosis. Inventiva develops a novel internal canc …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Neuraltus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus’ focuses on macrophage which …
  • Groupe Guillin SA:企業の戦略・SWOT・財務情報
    Groupe Guillin SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Guillin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • S-Oil Corporation Inc (010950)-石油・ガス分野:企業M&A・提携分析
    Summary S-Oil Corporation Inc (S-Oil) is a service driven company that operates in the petroleum and petrochemical industry. The company imports and exports crude oil; as well as manufactures and sells oil refining products, petrochemical products and lube products. S-Oil also produces a wide range …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Legal & General Group Plc:企業の戦略・SWOT・財務情報
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DAMAC Real Estate Development Ltd:企業の戦略・SWOT・財務情報
    DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bank Albilad:企業の戦略・SWOT・財務分析
    Bank Albilad - Strategy, SWOT and Corporate Finance Report Summary Bank Albilad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sinochem International Corp (600500):企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AAC Technologies Holdings Inc. (2018):企業の財務・戦略的SWOT分析
    AAC Technologies Holdings Inc. (2018) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Joincare Pharmaceutical Group Industry Co Ltd (600380):製薬・医療:M&Aディール及び事業提携情報
    Summary Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) is a manufacturer and supplier of pharmaceutical products. The company offers healthcare products, bulk prescription products, active pharmaceutical ingredients, OTC products, detection reagents, and food additives. Its healthca …
  • Sun-Rype Products Ltd.:企業の戦略・SWOT・財務情報
    Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆